Gene · 2817
Papers2,608
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,608
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 Receptors and Their Involvement in Cell Infection. | Biochem (Mosc) Suppl Ser A Membr Cell Biol | 2023 | 37008884 | PubTator, text mining | PubMed |
| Multidisciplinary team diagnosis and treatment of pancreatic cancer: Current landscape and future prospects. | Front Oncol | 2023 | 37007078 | PubTator, text mining | PubMed |
| Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles. | Front Mol Biosci | 2023 | 37006626 | PubTator, text mining | PubMed |
| Multifactor dimensionality reduction method identifies novel SNP interactions in the WNT protein interaction networks that are associated with recurrence risk in colorectal cancer. | Front Oncol | 2023 | 36998434 | PubTator, text mining | PubMed |
| Editorial: Growth and Tissue Regeneration with focus on Proteoglycans. | Front Cell Dev Biol | 2023 | 36994097 | PubTator, text mining | PubMed |
| Pancreatic Cancer Biomarkers: Oncogenic Mutations, Tissue and Liquid Biopsies, and Radiomics-A Review. | Dig Dis Sci | 2023 | 36988759 | PubTator, text mining | PubMed |
| Overview and New Insights into the Metabolic Syndrome: Risk Factors and Emerging Variables in the Development of Type 2 Diabetes and Cerebrocardiovascular Disease. | Medicina (Kaunas) | 2023 | 36984562 | PubTator, text mining | PubMed |
| The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment-A Systematic Review. | Cancers (Basel) | 2023 | 36980765 | PubTator, text mining | PubMed |
| The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers. | Cancers (Basel) | 2023 | 36980662 | PubTator, text mining | PubMed |
| Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection. | Biosensors (Basel) | 2023 | 36979608 | PubTator, text mining | PubMed |
| The glycoprotein CD147 defines miRNA-enriched extracellular vesicles that derive from cancer cells. | J Extracell Vesicles | 2023 | 36973758 | PubTator, text mining | PubMed |
| Design and Computational Analysis of an MMP9 Inhibitor in Hypoxia-Induced Glioblastoma Multiforme. | ACS Omega | 2023 | 36969457 | PubTator, text mining | PubMed |
| Development and validation of a CECT-based radiomics model for predicting IL1B expression and prognosis of head and neck squamous cell carcinoma. | Front Oncol | 2023 | 36969073 | PubTator, text mining | PubMed |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. | iScience | 2023 | 36968082 | PubTator, text mining | PubMed |
| The mechanisms underlying the enrichment and action of glypican-1-positive exosomes in colorectal cancer cells. | Transl Oncol | 2023 | 36963204 | PubTator, text mining | PubMed |
| Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior. | Oncotarget | 2023 | 36944188 | PubTator, text mining | PubMed |
| Exome-wide assessment of isolated biliary atresia: A report from the National Birth Defects Prevention Study using child-parent trios and a case-control design to identify novel rare variants. | Am J Med Genet A | 2023 | 36942736 | PubTator, text mining | PubMed |
| A deficiency screen of the 3rd chromosome for dominant modifiers of the Drosophila ER integral membrane protein, Jagunal. | G3 (Bethesda) | 2023 | 36932646 | PubTator, text mining | PubMed |
| Glycocalyx engineering with heparan sulfate mimetics attenuates Wnt activity during adipogenesis to promote glucose uptake and metabolism. | J Biol Chem | 2023 | 36931394 | PubTator, text mining | PubMed |
| COL3A1, CXCL8, VCAN, THBS2, and COL1A2 are correlated with the onset of biliary atresia. | Medicine (Baltimore) | 2023 | 36930067 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2817/papers?page=18